ADPT Sale Disclosure
Rubinstein Julie · SEC Form 4 · Filed Oct 26, 2026
Sale
Calculated transaction value
$186.59K
Rubinstein Julie President And COO
Transaction date
Oct 23, 2026
Public filing date
Oct 26, 2026
Filing lag
Filed 3 days later
ADPT daily price context
Close on/before transaction
$25.51
Oct 23, 2026
First close after public filing
$27.66
Oct 27, 2026
Return after filing · so far
+5.57%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,381 shares @ $25.28
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780664-26-000045
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.33M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 26, 2026 | $88.84K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 26, 2026 | $220.57K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 26, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 26, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 23, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT Current | Sale | Oct 23, 2026 | $186.59K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 23, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 23, 2026 | $110.25K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 22, 2026 | $248.21K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 22, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 22, 2026 | $42.99K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 22, 2026 | $0 |